BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9728801)

  • 1. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
    Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
    Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E; Pietruska Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F
    Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
    Haseeb MA; Shirazian DJ; Preis J
    Cytokine; 2001 Sep; 15(5):266-9. PubMed ID: 11594791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N; Yamaguchi S; Yamaoka M; Okuyama M; Nakamura H; Tomoike H
    J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
    Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients.
    Bellometti S; Galzigna L; Richelmi P; Gregotti C; Bertè F
    Int J Tissue React; 2002; 24(2):57-64. PubMed ID: 12182234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and heart rate variability in patients with chronic heart failure.
    Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
    Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.